Skip to Content
Merck
  • Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

PloS one (2013-04-05)
Adam S Kamlet, Constanze N Neumann, Eunsung Lee, Stephen M Carlin, Christian K Moseley, Nickeisha Stephenson, Jacob M Hooker, Tobias Ritter
ABSTRACT

New chemistry methods for the synthesis of radiolabeled small molecules have the potential to impact clinical positron emission tomography (PET) imaging, if they can be successfully translated. However, progression of modern reactions from the stage of synthetic chemistry development to the preparation of radiotracer doses ready for use in human PET imaging is challenging and rare. Here we describe the process of and the successful translation of a modern palladium-mediated fluorination reaction to non-human primate (NHP) baboon PET imaging-an important milestone on the path to human PET imaging. The method, which transforms [(18)F]fluoride into an electrophilic fluorination reagent, provides access to aryl-(18)F bonds that would be challenging to synthesize via conventional radiochemistry methods.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Paroxetine hydrochloride hemihydrate, ≥98% (HPLC), powder
Paroxetine for system suitability, European Pharmacopoeia (EP) Reference Standard
Paroxetine hydrochloride hemihydrate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Paroxetine maleate salt, ≥98% (HPLC), solid
Supelco
Paroxetine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®